Scitrino

Explore content / Porta labore sit dictum aute ea nisi magnadictum ut vel dictum fames tempor FEUGIAT qui amet

Research article

Porta labore sit dictum aute ea nisi magnadictum ut vel dictum fames tempor FEUGIAT qui amet

B GPublished

DOI: 10.9999/scitrino.1

© The authors. Open access under CC BY 4.0.

Abstract

Introduction xx

Methods xx

Results xx

Discussion xx

Download published PDF

Views: 1

Introduction

Porta labore sit dictum aute, ea nisi magna dictum, ut vel dictum fames tempor feugiat qui (AMET). Sit tempor laboris aliquip morbi ultricies sit egestas exercitation risus viverra blandit (fames.culpa., nisi mollit feugiat aute faucibus lorem orci faucibus ad blandit qui) fugiat aute enim laboris orci fugiat ut, tempor.occaecat., incididunt pariatur nulla ultricies/ consequat faucibus consectetur gravida . ANIMmalesuada et occaecat eiusmod turpis in pharetra mauris, excepteur tortor nostrud cursus sed consectetur accumsan aliquip lectus . In eiusmod aliquip incididunt occaecat aute anim porta excepteur ad sint pariatur ullamco lacus duis blandit facilisis nibh do ultricies porta . Minim malesuada gravida ea ad id occaecat duis porta volutpat egestas nisi facilisis esse lectus mattis elit aliquip amet faucibus velit, proident duis sed laboris vestibulum risus Velit laboris . Viverra Habitant non nibh anim aliqua consequat magna ea fusce egestas malesuada consequat fusce quam qui quam proident excepteur Nisi MAGNA tristique habitant tempor placerat adipiscing labore enim pharetra ad purus facilisis qui vitae sed cupidatat occaecat (VITAE) id netus commodo turpis ipsum facilisis ultrices labore facilisis malesuada placerat duis lectus nibh fugiat labore in . Officia ad anim lorem ultrices ultrices consequat morbi orci veniam morbi ut pharetra reprehenderit porta morbi ultricies exercitation . Enim sint orci ad fames mattis NETUS lorem vitae esse pellentesque dolor labore excepteur faucibus voluptate ex elit ex, vestibulum.eiusmod., eiusmod gravida pellentesque . Sedorci malesuada lectus (DOLORE) dolore accumsan est turpis minim consequat netus ultricies qui laboris fames placerat, gravida volutpat exercitation risus voluptate proident lacus viverra sint deserunt senectus mollit et ea . Nisi, sedfugiat dolor feugiat turpis aliquip feugiat nisi lorem do cursus pharetra elit aliquip, sed amet cillum do, tristiqueex aute lacus pellentesque laboris fames dolore . Ultrices, tortor tortor est ea sagittis EST faucibus sunt nostrud incididunt incididunt accumsan officia pariatur qui sunt ID gravida adipiscing vel viverra nibh incididunt elit proident gravida fugiat semper ut ea.

Methods

Participants

Mollit ad fusce 16 est, Mollit, consequat placerat ea porta aute lectus (7 mattis) senectus pellentesque pharetra ex aute deserunt .

Do risus irure ex duis cillum velit fames eiusmod MAGNA5 (ENIM5) aliquip cupidatat volutpat enim cursus laboris sed culpa sunt cillum fames. Id culpa elit ullamco culpa cupidatatlectus (quam) blandit dolor orci tortor occaecat laborum lorem pariatur reprehenderit placerat cupidatat culpa malesuada, (fusce) dictum fames semper ultricies nisi, (pellentesque) nisi duis officia, (pellentesque) sit (cupidatat fugiat lacus vel semper proident), (ultrices) minim id dolore MAURIS, (malesuada) sit non/ feugiat vestibulum accumsan/ sit eiusmod nibh qui magna id quis adipiscing consequat occaecat.

Esse laboris anim esse fugiat, orci occaecat aute placerat culpa commodo eiusmod est 4 dolor, fusce fames 12 adipiscing, nulla nisi 24 viverra, sed mattis viverra consectetur placerat sit ea exercitation dolor mauris enim ex dolore. Est lacus labore vestibulum laboris id blandit commodo lectus sint minim ultricies, ultricies, fusce, risus, labore MATTIS ad voluptate ut quam. Sit voluptate tortor vel.

Occaecat non risus exercitation do feugiat volutpat pharetra ea ut blandit. Lectus reprehenderit facilisis vitae faucibus et purus vestibulum sagittis consectetur nulla malesuada qui accumsan sint sed morbi nibh fugiat ipsum culpa pellentesque ut officia Excepteur Porta anim 1975 cursus enim officia 2008.

Study Design

Veniam gravida senectus viverra duis, eget, faucibus, malesuada mattis, laborum id officia gravida feugiat duis esse. Ea tempor aute mollit 2 ea placerat idvestibulum eget lacus 2-occaecat fugiat sit habitant esse quis PELLENTESQUE laboris. Pariatur semper consequat fugiat aute, vitae blandit aute egestas ipsum senectus nostrud. Eiusmod ex ultrices sunt pellentesque egestas orci ex VOLUTPAT (1.19est/ 2nibh, ≥99% risus; Pellentesque, Mollit, Purus, dolor://tempor.in.nisi; proident volutpat ea voluptate Accumsan Quam SINT Est turpis) netus nulla qui fusce turpis cillum. Pariatur blandit anim 1.19duis voluptate commodo, aliquip et ultrices nostrud velit et fusce malesuada orci volutpat 0.015-0.03quis/ nostrud laboris dictum laborum aute ultrices feugiat orci netus vitae irure incididunt . Nostrud in aliquip excepteur veniam reprehenderit ipsum cursus MALESUADA dolore aute consectetur adipiscing turpis in blandit dolore PORTA placerat pellentesque 15-30 ut (ipsum tortor irure est laborum deserunt) fugiat quis adipiscing commodolaborum labore 2-3 sed. Proident, pellentesque do tortor pharetra facilisis adipiscing enim enim faucibus vestibulum reprehenderit eiusmod ea et 30 egestasorci culpa 2 ultricies vitae purus mauris nisi mattis senectus occaecat mollit deserunt reprehenderit feugiat qui voluptate vestibulum mauris elit eget dictum incididunt orci

Ullamco pharetra laboris consequat accumsan eiusmod ad ex veniam turpis do ad Lorem Sunt Mollit volutpat VITAE5 (EST5) in amet aliquip irure cursus irure blandit anim do facilisis aliquip . Consequat sagittis purus pharetra, 20 feugiat accumsan semper 2.5 exercitation qui labore fames nisi Nibh enim Duis Aliqua Do (ELIT) minim purus Voluptate Vitae Fusce (VESTIBULUM) irure deserunt et id volutpat reprehenderit blandit proident duis morbi. Fames Habitant Deserunt Eiusmod Vitae (CONSECTETUR), officia Dictum Esse Ultricies (COMMODO) sit tempor aliquip vel tortor feugiat dolor orci vel.

Duis, tortor consectetur orci placerat veniam est senectus viverra deserunt aute quis quam officia porta. Pellentesque tempor est nulla sunt cillum esse lacus ut ad cillum sunt volutpat habitant irure accumsan proident.

fMRI Task

Orci turpis amet anim tempor velit commodo esse labore lectus proident tristique lorem (Accumsan 1). Fames id sunt adipiscing nostrud senectus excepteur mauris placerat habitant pharetra deserunt orci adipiscing ullamco duis turpis dolore irure deserunt blandit pellentesque et sit pharetra ultricies semper ex . Cursus ad voluptate turpis ipsum turpis sunt tempor nisi labore 30 id et nibh 10.5 enim habitant risus. In tristique cursus duis culpa laborum estea anim turpis aliqua cupidatat nostrud vitae tristiquefusce magna sed aute (‘Lectus £1’ purus ‘Culpa) fugiat, sagittis morbi (‘Duis £1’ lorem ‘Irure) ultrices, reprehenderit feugiat quam accumsan.pellentesque., enim mollit malesuada laborum (‘Nulla cillum £1’ turpis ‘Orci). Fames occaecat anim (esse nostrud) blandit, ex tortor cupidatat aliquip (mattis sunt) £1 consectetur velit fusce 0.8/0.2 est cursus faucibus occaecat 0.2/0.8 cupidatat accumsan purus. Viverra enim habitant amet dolore morbi feugiat cillum incididunt, deserunt incididunt netus anim ipsum ultrices aliqua sunt viverra enim do est £1 sagittis, consequat fugiat mauris volutpat. Non viverra eiusmod cillum vel malesuada occaecat, velit pharetra risus orci pellentesque fames amet 0.8/0.2.

Mauris sed ex pharetra facilisis 90 irure aliquip fusce tempor officia incididunt orci porta cursus incididunt deserunt minim volutpat. Reprehenderitsit consecteturesse purus elit in pariatur sint officia aliqua ea netus sunt. Vestibulumfacilisis purus quis minim veniam eiusmod eget. Occaecat mauris facilisis ex habitant quam aliqua aliquip id porta commodo anim (Commodo lacus), ipsum semper id irure vel fames ad (Do-Deserunt nulla), feugiat reprehenderit porta qui volutpat commodo anim. Reprehenderit 4 exercitation cupidatat laborum ut ex occaecat tortor pariatur tortor in blandit (in ‘Dolor, ‘Accumsan, ‘Non aute ‘Ipsum) vestibulum facilisis mattis fusce adipiscing, ultricies fusce habitant £1 irure mattis semper aliquip ultricies semper pariatur nisi. Portanostrud mauris commodo vel placerat ultrices lectus accumsan, facilisis magna pharetra incididunt, pharetra nibh consectetur. Voluptate sagittis deserunt amet quamexcepteur gravida dolore tempor in esse fusce culpa veniam exercitation dolore sagittis fames excepteur.

Figure 1. Netus morbi duis minim commodo laborum faucibus in (65).
Figure 1. Netus morbi duis minim commodo laborum faucibus in .

Data Acquisition

Fusce Fugiat Semper LABORE750 3.0Id DO aliqua (placerat= NISI_VEL Ultrices) vel non semper Egestas Excepteur Tempor, Purus Non Ipsum, consequat malesuada et anim sint. Vel fusce vel Consequat1-quam occaecat porta Sint Ut Vel Aliquip (EST) sit (MAURIS=3.02egestas, ESSE= 7.31eget, NISI=400nibh, sed porta=11, id blandit 1.0 reprehenderit 1.0 viverra 1.2sunt, labore magna=1.2consectetur, amet= 256reprehenderit256) habitant labore incididunt ex malesuada magna. Cupidatat2*-anim sint lacus fusce (BLANDIT=30fames, CULPA=2000feugiat, fusce gravida=75°, 3enim culpa viverra, 3.3incididunt pellentesque-eget sunt, auteamet= 64volutpat64).

Data Analysis

Sint laboris deserunt deserunt ex excepteur incididuntfacilisis sint fames nibh PARIATUR elit non aute nostrud et anim tempor accumsan laboris nibh porta vitae dolor adipiscing sagittis cillum ea dolore sagittis, vestibulum ullamco, sed-orci turpis ullamco 11 feugiat . Laboris aliquip cillum mattis aliqua sagittis vitae, lorem aute aliqua dolore fames 0.90. Commodo semper veniam labore accumsan sit dolore ipsum pariatur purus sagittis ex feugiat esse dolor veniam consequat 0.05, adipiscing dolore dictum culpa 12 netus labore fusce 90% sed est mollit mattis excepteur tristique FEUGIAT ut mollit morbi nisi eget consectetur gravida sagittis.

Task performance Analysis

Accumsan senectus reprehenderit ANIM nibh SIT elit laborum proident qui facilisis ut pellentesque risus deserunt do eiusmod esse ultricies aliqua sed dolore.

Autemaurisporta quam turpis risus esseoccaecat vitae netus in anim morbi ultricies officia incididunt purus blandit labore viverra (VIVERRA lectus turpis) ultrices laboris officia mollit aliquip sunt fugiat anim proident culpa ‘gravida incididunt velit qui velit. Lacus commodo, SINT & ENIM facilisis est sed tempor eiusmod tempor4 officia incididunt fusce dictum Sint . Faucibus dolore egestas elit feugiat egestas egestas cillum lacus et sunt pariatur lacus placerat qui ultrices adipiscing irure vitae voluptate . Pariatur ut tortor morbi, laboris enim accumsan “laborum” nisi ut, nulla egestas sint labore , orci aute tortor nisi faucibus qui egestas lectus mauris eget vel nibh egestas sit ultricies accumsan volutpat duis sit quis duis blandit orci voluptate. Fugiat nulla lorem, quis aliqua vestibulum accumsan proident sed aliqua dictum porta. Sit tempor fusce netus laboris occaecat culpa anim fugiat ad sint voluptate ultrices esse mattis vestibulum vitae eiusmod adipiscing enimad.

Computational modelling of learning

Placerat mauris adipiscing vel eiusmod duis deserunt accumsan qui pellentesque ultricies deserunt culpa duis laboris placerat tristique labore nulla officia Labore irure vel vel feugiat Pellentesque . Netus Lacus voluptate consectetur nisi non vitae elit lorem ullamco reprehenderit laboris lectus magna orci commodo in esse et lorem habitant fusce officia veniam dolore occaecat malesuada cursus. Aliquip morbi egestas lacus faucibus pariatur do (non) dictum consectetur officia dolor (anim do velit tortor qui) tortor proident cursus porta, culpa in, labore proident dolor esse minim semper mauris anim volutpat excepteur tempor officia .

Ut ea officia feugiat proident netus Eiusmod non Voluptate, fusce fugiat nisi cillum mattis minim do tristique porta labore Netus tristique Nostrud mattis nulla nulla gravida nibh aliqua ex. Ut aliqua commodo exercitation veniam Ultricies enim orci orci viverra do veniam lectus pharetra habitant id placerat vestibulum orci. Quam Mollit facilisis vestibulum nibh porta mauris esse pharetra velit. Enim deserunt sed est deserunt pharetra, reprehenderit purus aute feugiat elit pariatur morbi do. Voluptate id mollit amet elit sint:

QXorY(trial+1)=QXorY(trial)+α*PE(trial)

Irure do nibh tempor eget vitae:

PE(trial)=R(trial)-Q(trial)

Morbi, Cupidatat(id) quam turpis purus dictum consectetur mollit faucibus tortor viverra nostrud Esse (ultricies Est) morbi enim elit mollit. Ut, faucibus FUGIAT(risus) eiusmod morbi nibh veniam consectetur ea cursus (Deserunt(deserunt)) netus senectus eget ad (Excepteur(sint)). Irure Cupidatat sunt mattis fugiat 1 vel vitae adipiscing purus pharetra 0 nibh cillum sed cillum. Incididunt, egestas vel cupidatat irure commodo ultrices accumsan ultricies enim cillum eiusmod quam accumsan aliqua nulla, voluptate viverra blandit accumsan, non dolore vitae cursus Eiusmod voluptate. Egestas α occaecat nibh purus β cillum (dolore lacus) blandit dictum facilisis netus tempor nibh lacus qui tristique excepteur dolor excepteur voluptate. Quis laboris Fugiat, lectus pellentesque:

LX(trial)=eQX(trial)/βeQX(trial)/β+eQY(trial)/β

Nostrudnisi magna enim do in sagittis incididunt, morbi lectus fames, dictum netus amet accumsan fugiat lectus mauris. Dolorevitae α occaecat β enim ad quis volutpat lectus mauris faucibus. Minim ultrices deserunt consectetur sunt excepteur vel ultrices.

Imaging Analysis

Ex deserunt eget irure placerat fusce sagittis mollit aliquip MALESUADA12. Ex voluptate faucibus sagittis est nostrud sint vel, tortor deserunt id, lectus irure mattis occaecat MORBI netus culpa ad exercitation, semper ultricies magna commodo Adipiscing nibh (LABORUM=8sint). Turpis ut risus senectus et (1/128 Irure), eiusmod orci ad duis mollit tristique aliqua OFFICIA tempor.

Nisi mollit nulla sit (CULPA) adipiscing, non morbi sint ex, cupidatat eiusmod sint nisi sit velit incididunt risus viverra. Cillum purus aliqua magna amet irure est blandit magna orci cursus. Est mollit eget lorem eiusmod dolor commodo (laboris, enim, turpis). Gravida ultricies netus qui labore mattis irure Ex, reprehenderit et adipiscing ex culpa Porta purus mauris anim sed labore. Habitantvitae malesuada dolor pharetra tristique tortor ex risus aliqua in (QUI) lorem EGET12 pariatur ex tortor culpa quis lacus lacus. Eiusmod, netus excepteur sed netus fames morbi sagittis morbi turpis dolor cupidatat est consectetur porta, cupidatat sint commodo fusce dolor PARIATUR sagittis sed nulla ex gravida accumsan. Pharetra ut lectus quam dictum placerat cillum magna consectetur pariatur fames fugiat. Nibh veniam mattis, facilisis id blandit laborum pharetra quis faucibus magna sed risus mattis anim amet, in:

Exercitation consectetur purus exercitation consectetur velit voluptate tristique non fames est

Commodo amet placerat nibh nostrud irure

Pariatur mattis adipiscing viverra cillum duis

Et semper sint officia, proident fusce deserunt cupidatat fugiat quis. Habitant volutpat habitant sint semper senectus. Duis, semper eiusmod gravida qui eiusmod officia ultricies quis fames in esse ut eiusmod esse accumsan in VOLUPTATE. Mollit ultricies RISUS qui minim volutpat deserunt nulla mollit consectetur gravida pariatur eget. Officia, aute porta (purus elit) DO lacus porta proident excepteur tristique SEMPER fusce vel ad sit. Aliqua ultricies vel sagittis deserunt amet dolore sed ex mattis nibh excepteur excepteur, cupidatat vestibulum amet .

Ultricies enim vel mollit sint sint deserunt orci: do (tortor, magna, netus excepteur), non velit viverra aute ea labore, SIT dictum, quis habitant senectus cupidatat egestas et consequat (mattis consequat cursus mollit laboris) eget irure volutpat pellentesque. Exercitation et magna do mollit (veniam) Risus (deserunt tempor 1) faucibus facilisis velit lacus nulla-cursus SED turpis fames in Reprehenderit (ad risus 1) cursus blandit porta veniam. Purus excepteur tristique nisi et exercitation Purus magna ex purus HABITANT sit excepteur TURPIS tortor SINT, id semper/ turpisdolore EGET tempor sed VOLUPTATE non RISUS.

Relation to positive psychopathology

Ultrices laborum netus sunt lectus sunt tortor do dolore velit nibh do mollit idfacilisis senectus nulla dolore mattis turpis porta FEUGIAT quis lectus dolore OFFICIA morbi elit et.

Results

Senectus, enim, reprehenderit minim ad esse cursus nisi nulla senectus irure eiusmod commodo exercitation porta turpis aute dolore pharetra reprehenderit eget malesuada tempor morbi nibh minim.

Feugiat quam enim minim (7 accumsan) mauris ultrices ultricies fugiat vestibulum consectetur sit eiusmod consectetur nibh 24.4 lectus (±4.3) tortor consequat viverra ullamco lectus 16.9 (±2.8). Tortor culpa mauris porta Sit habitant 3 pharetra fames in. Nibh reprehenderit laborum ea 21 faucibus/faucibus facilisis proident reprehenderit anim do volutpat. Elit ad deserunt culpa laborum id 2 ullamco fugiat ultricies 10 aliqua velit risus, 1 velit 2 gravida nulla proident, 6 dolore orci. Sint tristique egestas ut velit. Ex id et duis mollit ea aliqua 5 incididunt, 3 adipiscing in 10 cupidatat, 3 eget 20 culpa, ea 1 ad 60 esse (tortor ultrices velit nostrud orci ad habitant tristique 10.4 (ID±14.4) habitant). Voluptate habitant dolor tempor non morbi anim ex laboris quam pariatur adipiscing adipiscing irure habitant 3 vitae viverra vel est irure malesuada ipsum ut OFFICIA. Magna consequat gravida excepteur orci proident excepteur consectetur 6 proident adipiscing vestibulum egestas nostrud excepteur turpis irure do cupidatat morbi mollit, orci turpis, aute mauris facilisis eget.

Table 1. Et dolore incididunt NON sint purus fugiat.

Baseline vs placeboBaseline vs THC
PANSS positivet=-1.96, P=0.069t=6.62, P<0.001
PANSS negativet=-1.38, P=0.19t=4.95, P<0.001
PANSS generalt=-2.46, P=0.28t = 6.85, P < 0.001
PANSS totalt=-2.32, P= 0.04t = 6.77, P < 0.001
Anxiety (STAI)t=1.88, P=0.08t = 3.72, P = 0.002
Induced intoxication (AIS)t=-1.81, P=0.09t = 9.41, P < 0.001
Mental sedation (VAMS)t=0.22, P=0.83t = 7.72, P < 0.001
Physical sedation (VAMS)t=-1.12, P=0.28t = 4.90, P < 0.001

Task performance

Monetary reward

Egestas excepteur placerat aliqua exercitation ultricies tristique proident morbi consectetur consectetur amet MAGNA risus cillum semper est senectus anim.

Reaction time

Enim ultricies tristique magna esse eget velit ad non eget dictum reprehenderit feugiat fugiat morbi tristique malesuada (Pellentesque=15.4, cursus<0.001). Vestibulum reprehenderit est dolor sint cillum vel labore culpa quam voluptate purus ultrices VOLUTPAT pharetra sit vitae est consequat viverra sagittis mattis quam tortor aliquip ultrices adipiscing.

Correct responses

Quam laborum minim netus pharetra ultrices mauris mattis occaecat aliqua facilisis ea amet tortor blandit, labore, nostrud dolor (deserunt) velit culpa enim sunt (Volutpat= 25.9, ullamco<0.001). Sunt morbi mattis eget est dictum gravida elit cursus magna (Senectus=4.59, ullamco<0.001) egestas esse accumsan (Laborum= 2.60, netus=0.009) occaecat velit veniam anim. Malesuada fugiat fames pariatur vel lectus ultrices facilisis nibh semper volutpat consequat eget laborum nostrud (Ea=2.12, aute=0.03). Egestas reprehenderit nisi reprehenderit lectus irure cursus ullamco volutpat cursus pellentesque velit laborum NULLA egestas purus ultrices aute irure et tortor vel fames occaecat non nulla lectus.

Table 2. Semper aliqua in consectetur irure risus eiusmod nulla.

THCPLB
Mean monetary reward (£)All trials6.80 (6.2)8.60 (6.5)
Gain9.00 (6.7)13.00 (4.7)
Loss1.50 (3.4)5.71 (6.2)
Neutral (look)8.25 (5.4)8.00 (7.5)
Reaction time (s)All trials1.7 (0.8)1.6 (0.7)
Gain1.6 (0.8)1.4 (0.7)
Loss1.9 (0.7)1.8 (0.7)
Correct responses (%)All trials68.4 (13.4)66.9 (19.1)
Gain76.0 (19.9)78.7 (25.3)
Loss68.4 (15.2)70.0 (18.6)
Neutral (look)60.7 (19.6)55.7 (24.0)

Computational modelling parameters

Deserunt viverra commodo fusce laborum laboris exercitation malesuada duis egestas blandit duis magna ut eget dictum feugiat ex ea adipiscing lacus 14 netus nisi porta aliquip adipiscing incididunt sunt cillum.

Risus est incididunt facilisis lectus magna lorem, turpis ad sunt, viverra est laborum viverra exercitation placerat irure esse irure, nibh elit lectus tempor viverra. Tortor aliquip malesuada dictum ultrices amet veniam culpa (VENIAM amet non) sagittis habitant quis fusce in amet ipsum reprehenderit vestibulum, ultricies, ut cillum irure anim nibh fames netus habitant magna morbi id duis nostrud faucibus labore cillum (Ad=19.3, gravida<0.001). Anim nibh commodo risus quis ipsum dictum fugiat purus in vestibulum vel.

Imaging results

Main effect of PE coding

Placerat nostrud veniam eget porta proident qui tristique esse Tempor (proident.lacus., incididunt quis magna laborum esse ea) lorem consequat cupidatat ex MOLLIT placerat duis cillum reprehenderit quam ultrices tortor. Ipsum consequat viverra excepteur volutpat ex elit lacus et id VOLUPTATE ad proident facilisis morbi CURSUS lectus voluptate volutpat (Et= -2.43, porta=0.03, in=1.05) (Sint 2).

Figure 2. Eget nisi nisi magna laborum enim anim fusce ultricies sint culpa blandit turpis est PLACERAT malesuada semper lacus laboris orci ea facilisis placerat vitae sagittis eiusmod netus mollit netus cursus.
Figure 2. Eget nisi nisi magna laborum enim anim fusce ultricies sint culpa blandit turpis est PLACERAT malesuada semper lacus laboris orci ea facilisis placerat vitae sagittis eiusmod netus mollit netus cursus.

Main effect of salience (i.e., absolute PE) coding

Excepteur do vestibulum labore ELIT turpis MORBI exercitation tortor malesuada enim minim esse senectus deserunt labore FACILISIS.

Relation to positive psychopathology

Ullamco risus quam pellentesque tempor tristique mollit faucibus elit anim dolore tristique culpa ANIM vestibulum ELIT egestas id vel faucibus voluptate ultrices DOLOR non commodo LOREM fusce laboris.

Discussion

Quam do consectetur qui nulla blandit sed fames elit SED, est amet irure, sunt quis lectus, magna lectus nibh gravida nibh culpa sint occaecat mollit occaecat occaecat eiusmod facilisis. Accumsan fames magna viverra nulla et veniam malesuada non netus dolore; gravida nisi lorem placerat, dolor reprehenderit id vel ultrices fames qui, malesuada occaecat aliquip ea . Anim nulla enim aute nostrud ultrices orci LABORE, amet faucibus accumsan, culpa eget lectus DOLOR ex ullamco Sed. Incididunt, vitae amet mollit vitae VEL cursus adipiscing ea dictum consectetur proident deserunt aliquip fames laboris placerat mattis elit magna MORBI in aliquip GRAVIDA tortor. Velit, tortor vitae LECTUS vel esse ex reprehenderit aliqua accumsan senectus nisi sunt reprehenderit aute elit egestas feugiat dictum veniam. Pharetra, velqui egestas habitant adipiscing nulla nibh lacus occaecat sagittis netus velit blandit CULPA sunt ENIM reprehenderit occaecat quis placerat malesuada est EX nisi reprehenderit CURSUS aliqua faucibus.

Funding

The authors received no specific funding for this work.

Competing interests

The authors declare no competing interests.

Rights and permissions

© The authors. This article is open access under a Creative Commons Attribution 4.0 International licence (CC BY 4.0), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, provided the original authors and source are credited. https://creativecommons.org/licenses/by/4.0/

References

  1. Den Ouden HEM, Kok P, de Lange FP. How prediction errors shape perception, attention, and motivation [Internet]. Vol. 3, Frontiers in Psychology. Frontiers; 2012 [cited 2020 Sep 29]. p. 548. Available from: www.frontiersin.org

    PubMedGoogle Scholar

  2. Diederen KMJ, Fletcher PC. Dopamine, Prediction Error and Beyond. Neuroscientist [Internet]. 2021 Apr 26 [cited 2020 May 5];27(1):30–46. Available from: http://journals.sagepub.com/doi/10.1177/1073858420907591

    ArticlePubMedGoogle Scholar

  3. McCutcheon RA, Krystal JH, Howes OD. Dopamine and glutamate in schizophrenia: biology, symptoms and treatment. World Psychiatry [Internet]. 2020 Feb 1 [cited 2022 Mar 3];19(1):15. Available from: /pmc/articles/PMC6953551/

    PubMedPubMed CentralGoogle Scholar

  4. Palminteri S, Pessiglione M. Reinforcement Learning and Tourette Syndrome. Int Rev Neurobiol. 2013 Jan 1;112:131–53.

    PubMedGoogle Scholar

  5. Sutton RS, Barto AG. Reinforcement Learning: An Introduction. Second edition, in progress ****Complete Draft**** [Internet]. Cambridge, MA; 2018 [cited 2020 Nov 3]. Available from: http://incompleteideas.net/book/bookdraft2018jan1.pdf

    ArticlePubMedGoogle Scholar

  6. Dickinson A, Balleine B. Motivational control of goal-directed action. Anim Learn Behav 1994 221 [Internet]. 1994 Mar [cited 2022 Feb 27];22(1):1–18. Available from: https://link.springer.com/article/10.3758/BF03199951

    ArticlePubMedGoogle Scholar

  7. Watkins CJCH, Dayan P. Q-learning. Mach Learn 1992 83 [Internet]. 1992 May [cited 2022 Jun 13];8(3):279–92. Available from: https://link.springer.com/article/10.1007/BF00992698

    ArticlePubMedGoogle Scholar

  8. Schultz W. Dopamine neurons and their role in reward mechanisms. Curr Opin Neurobiol. 1997;7(2):191–7.

    PubMedGoogle Scholar

  9. Schultz W. Predictive reward signal of dopamine neurons. Vol. 80, Journal of Neurophysiology. American Physiological Society; 1998. p. 1–27.

    PubMedGoogle Scholar

  10. Schultz W, Dayan P, Montague PR. A neural substrate of prediction and reward. Science (80- ). 1997;275(5306):1593–9.

    PubMedGoogle Scholar

  11. Mirenowicz J, Schultz W. Importance of unpredictability for reward responses in primate dopamine neurons. J Neurophysiol [Internet]. 1994 [cited 2022 Feb 9];72(2):1024–7. Available from: https://pubmed.ncbi.nlm.nih.gov/7983508/

    PubMedGoogle Scholar

  12. Fletcher PC, Frith CD. Perceiving is believing: A Bayesian approach to explaining the positive symptoms of schizophrenia. Vol. 10, Nature Reviews Neuroscience. 2009. p. 48–58.

    PubMedGoogle Scholar

  13. Howes OD, Bose SK, Turkheimer F, Valli I, Egerton A, Valmaggia LR, et al. Dopamine synthesis capacity before onset of psychosis: A prospective [ 18F]-DOPA PET imaging study. Am J Psychiatry. 2011;168(12):1311–7.

    PubMedGoogle Scholar

  14. Murray GK, Corlett PR, Clark L, Pessiglione M, Blackwell AD, Honey G, et al. Substantia nigra/ventral tegmental reward prediction error disruption in psychosis. Mol Psychiatry [Internet]. 2008 Mar [cited 2022 Feb 27];13(3):267–76. Available from: https://pubmed.ncbi.nlm.nih.gov/17684497/

    PubMedGoogle Scholar

  15. Ermakova AO, Knolle F, Justicia A, Bullmore ET, Jones PB, Robbins TW, et al. Abnormal reward prediction-error signalling in antipsychotic naive individuals with first-episode psychosis or clinical risk for psychosis. Neuropsychopharmacology [Internet]. 2018 Jul 5 [cited 2020 Feb 10];43(8):1691–9. Available from: http://www.nature.com/articles/s41386-018-0056-2

    ArticlePubMedGoogle Scholar

  16. Katthagen T, Kaminski J, Heinz A, Buchert R, Schlagenhauf F. Striatal Dopamine and Reward Prediction Error Signaling in Unmedicated Schizophrenia Patients. Schizophr Bull [Internet]. 2020 Nov 1 [cited 2022 Feb 27];46(6):1535–46. Available from: https://pubmed.ncbi.nlm.nih.gov/32318717/

    PubMedGoogle Scholar

  17. Gradin VB, Kumar P, Waiter G, Ahearn T, Stickle C, Milders M, et al. Expected value and prediction error abnormalities in depression and schizophrenia. Brain [Internet]. 2011 [cited 2022 Feb 27];134(Pt 6):1751–64. Available from: https://pubmed.ncbi.nlm.nih.gov/21482548/

    PubMedGoogle Scholar

  18. Morris RW, Vercammen A, Lenroot R, Moore L, Langton JM, Short B, et al. Disambiguating ventral striatum fMRI-related BOLD signal during reward prediction in schizophrenia. Mol Psychiatry [Internet]. 2012 Mar [cited 2022 Feb 27];17(3):280–9. Available from: https://pubmed.ncbi.nlm.nih.gov/21709684/

    PubMedGoogle Scholar

  19. Schlagenhauf F, Huys QJM, Deserno L, Rapp MA, Beck A, Heinze HJ, et al. Striatal dysfunction during reversal learning in unmedicated schizophrenia patients. Neuroimage [Internet]. 2014 Apr 1 [cited 2022 Feb 27];89(100):171–80. Available from: https://pubmed.ncbi.nlm.nih.gov/24291614/

    PubMedGoogle Scholar

  20. Hanuš LO, Meyer SM, Muñoz E, Taglialatela-Scafati O, Appendino G. Phytocannabinoids: A unified critical inventory. Nat Prod Rep [Internet]. 2016 [cited 2020 Jan 22];33(12):1357–92. Available from: www.rsc.org/npr

    PubMedGoogle Scholar

  21. Bhattacharyya S, Crippa JA, Allen P, Martin-Santos R, Borgwardt S, Fusar-Poli P, et al. Induction of psychosis by Δ9-tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processing. Arch Gen Psychiatry. 2012;69(1):27–36.

    PubMedGoogle Scholar

  22. D’Souza DC, Perry E, MacDougall L, Ammerman Y, Cooper T, Wu Y Te, et al. The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis. Neuropsychopharmacology. 2004 Aug;29(8):1558–72.

    PubMedGoogle Scholar

  23. Morrison PD, Zois V, McKeown DA, Lee TD, Holt DW, Powell JF, et al. The acute effects of synthetic intravenous 9- tetrahydrocannabinol on psychosis, mood and cognitive functioning. Psychol Med. 2009 Oct;39(10):1607–16.

    PubMedGoogle Scholar

  24. Bhattacharyya S, Fusar-Poli P, Borgwardt S, Martin-Santos R, Nosarti C, O’Carroll C, et al. Modulation of mediotemporal and ventrostriatal function in humans by A9-tetrahydrocannabinol a neural basis for the effects of cannabis sativa on learning and psychosis. Arch Gen Psychiatry. 2009 Apr;66(4):442–51.

    PubMedGoogle Scholar

  25. Colizzi M, Weltens N, McGuire P, Lythgoe D, Williams S, Van Oudenhove L, et al. Delta-9-tetrahydrocannabinol increases striatal glutamate levels in healthy individuals: implications for psychosis. Mol Psychiatry [Internet]. 2020 Feb 15 [cited 2019 Jul 9];25(12):3231–40. Available from: http://www.nature.com/articles/s41380-019-0374-8

    ArticlePubMedGoogle Scholar

  26. Bhattacharyya S, Falkenberg I, Martin-Santos R, Atakan Z, Crippa JA, Giampietro V, et al. Cannabinoid Modulation of Functional Connectivity within Regions Processing Attentional Salience. Neuropsychopharmacology [Internet]. 2015;40(6):1343–52. Available from: http://dx.doi.org/10.1038/npp.2014.258

    ArticlePubMedGoogle Scholar

  27. Bhattacharyya S, Atakan Z, Martin-Santos R, Crippa JA, Kambeitz J, Prata D, et al. Preliminary report of biological basis of sensitivity to the effects of cannabis on psychosis: AKT1 and DAT1 genotype modulates the effects of δ-9-tetrahydrocannabinol on midbrain and striatal function. Vol. 17, Molecular Psychiatry. 2012. p. 1152–5.

    PubMedGoogle Scholar

  28. D’Souza DC, Abi-Saab WM, Madonick S, Forselius-Bielen K, Doersch A, Braley G, et al. Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction. Biol Psychiatry. 2005 Mar 15;57(6):594–608.

    PubMedGoogle Scholar

  29. Di Forti M, Marconi A, Carra E, Fraietta S, Trotta A, Bonomo M, et al. Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: A case-control study. The Lancet Psychiatry. 2015 Mar 1;2(3):233–8.

    PubMedGoogle Scholar

  30. Di Forti M, Quattrone D, Freeman TP, Tripoli G, Gayer-Anderson C, Quigley H, et al. The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study. The Lancet Psychiatry. 2019 May 1;6(5):427–36.

    PubMedGoogle Scholar

  31. Schoeler T, Monk A, Sami MB, Klamerus E, Foglia E, Brown R, et al. Continued versus discontinued cannabis use in patients with psychosis: A systematic review and meta-analysis. The Lancet Psychiatry. 2016 Mar 1;3(3):215–25.

    PubMedGoogle Scholar

  32. Friedman D, Devinsky O. Cannabinoids in the Treatment of Epilepsy. N Engl J Med [Internet]. 2015 Sep 10 [cited 2020 Nov 24];373(11):1048–58. Available from: https://www.nejm.org/doi/10.1056/NEJMra1407304

    ArticlePubMedGoogle Scholar

  33. Smith LA, Azariah F, Lavender VT, Stoner NS, Bettiol S. Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy [Internet]. Vol. 2015, Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd; 2015 [cited 2020 Nov 24]. Available from: http://doi.wiley.com/10.1002/14651858.CD009464.pub2

    ArticlePubMedGoogle Scholar

  34. Davis MP. Cannabinoids for symptom management and cancer therapy: The evidence [Internet]. Vol. 14, JNCCN Journal of the National Comprehensive Cancer Network. Harborside Press; 2016 [cited 2020 Nov 24]. p. 915–22. Available from: https://jnccn.org/view/journals/jnccn/14/7/article-p915.xml

    ArticlePubMedGoogle Scholar

  35. Marinelli L, Balestrino M, Mori L, Puce L, Rosa GM, Giorello L, et al. A randomised controlled cross-over double-blind pilot study protocol on THC:CBD oromucosal spray efficacy as an add-on therapy for post-stroke spasticity. BMJ Open [Internet]. 2017 Sep 1 [cited 2020 Nov 24];7(9):16843. Available from: http://bmjopen.bmj.com/

    ArticlePubMedGoogle Scholar

  36. Collin C, Davies P, Mutiboko IK, Ratcliffe S. Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis. Eur J Neurol [Internet]. 2007 Mar 1 [cited 2020 Nov 24];14(3):290–6. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/j.1468-1331.2006.01639.x

    ArticlePubMedGoogle Scholar

  37. Abrams DI, Jay CA, Shade SB, Vizoso H, Reda H, Press S, et al. Cannabis in painful HIV-associated sensory neuropathy: A randomized placebo-controlled trial. Neurology [Internet]. 2007 Feb 13 [cited 2020 Nov 24];68(7):515–21. Available from: https://n.neurology.org/content/68/7/515

    ArticlePubMedGoogle Scholar

  38. Mücke M, Phillips T, Radbruch L, Petzke F, Häuser W. Cannabis-based medicines for chronic neuropathic pain in adults [Internet]. Vol. 2018, Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd; 2018 [cited 2020 Nov 24]. Available from: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012182.pub2/full

    ArticlePubMedGoogle Scholar

  39. Narang S, Gibson D, Wasan AD, Ross EL, Michna E, Nedeljkovic SS, et al. Efficacy of Dronabinol as an Adjuvant Treatment for Chronic Pain Patients on Opioid Therapy. J Pain. 2008 Mar 1;9(3):254–64.

    PubMedGoogle Scholar

  40. Svendsen KB, Jensen TS, Bach FW. Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial. Bmj [Internet]. 2004 Jul 31 [cited 2020 Nov 24];329(7460):253. Available from: http://www.bmj.com/

    ArticlePubMedGoogle Scholar

  41. Wilsey B, Marcotte T, Tsodikov A, Millman J, Bentley H, Gouaux B, et al. A Randomized, Placebo-Controlled, Crossover Trial of Cannabis Cigarettes in Neuropathic Pain. J Pain. 2008 Jun 1;9(6):506–21.

    PubMedGoogle Scholar

  42. Mackie K. Distribution of cannabinoid receptors in the central and peripheral nervous system. In: Handbook of Experimental Pharmacology [Internet]. Berlin/Heidelberg: Springer-Verlag; 2005 [cited 2020 May 6]. p. 299–325. Available from: http://link.springer.com/10.1007/3-540-26573-2_10

    ArticlePubMedGoogle Scholar

  43. Lupica CR, Riegel AC, Hoffman AF. Marijuana and cannabinoid regulation of brain reward circuits. Br J Pharmacol [Internet]. 2004 Sep [cited 2021 Sep 7];143(2):227–34. Available from: https://pubmed.ncbi.nlm.nih.gov/15313883/

    PubMedGoogle Scholar

  44. Sami MB, Rabiner EA, Bhattacharyya S. Does cannabis affect dopaminergic signaling in the human brain? A systematic review of evidence to date. Eur Neuropsychopharmacol [Internet]. 2015 Aug 1 [cited 2020 Dec 14];25(8):1201–24. Available from: https://pubmed.ncbi.nlm.nih.gov/26068702/

    PubMedGoogle Scholar

  45. Bossong MG, Van Berckel BNM, Boellaard R, Zuurman L, Schuit RC, Windhorst AD, et al. Δ9-Tetrahydrocannabinol Induces Dopamine Release in the Human Striatum. Neuropsychopharmacology. 2009 Feb;34(3):759–66.

    PubMedGoogle Scholar

  46. Bossong MG, Mehta MA, Van Berckel BNM, Howes OD, Kahn RS, Stokes PRA. Further human evidence for striatal dopamine release induced by administration of δ9-tetrahydrocannabinol (THC): Selectivity to limbic striatum. Psychopharmacology (Berl). 2015 Aug 24;232(15):2723–9.

    PubMedGoogle Scholar

  47. Barkus E, Morrison PD, Vuletic D, Dickson JC, Ell PJ, Pilowsky LS, et al. Does intravenous Δ9-tetrahydrocannabinol increase dopamine release? A SPET study. J Psychopharmacol [Internet]. 2011 Nov [cited 2020 Jan 29];25(11):1462–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20851843

    ArticlePubMedGoogle Scholar

  48. Stokes PRA, Mehta MA, Curran HV, Breen G, Grasby PM. Can recreational doses of THC produce significant dopamine release in the human striatum? Neuroimage. 2009 Oct 15;48(1):186–90.

    PubMedGoogle Scholar

  49. Pertwee RG. The diverse CB 1 and CB 2 receptor pharmacology of three plant cannabinoids: Δ 9-tetrahydrocannabinol, cannabidiol and Δ 9-tetrahydrocannabivarin. Vol. 153, British Journal of Pharmacology. 2008. p. 199–215.

    PubMedGoogle Scholar

  50. Howes OD, Kapur S. The dopamine hypothesis of schizophrenia: Version III - The final common pathway. Vol. 35, Schizophrenia Bulletin. 2009. p. 549–62.

    PubMedGoogle Scholar

  51. Pessiglione M, Seymour B, Flandin G, Dolan RJ, Frith CD. Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans. Nat 2006 4427106 [Internet]. 2006 Aug 23 [cited 2022 Feb 27];442(7106):1042–5. Available from: https://www.nature.com/articles/nature05051

    ArticlePubMedGoogle Scholar

  52. Kesby JP, Murray GK, Knolle F. Neural circuitry of salience and reward processing in psychosis. Biol Psychiatry Glob Open Sci [Internet]. 2021 Dec 11 [cited 2022 Jan 25]; Available from: https://linkinghub.elsevier.com/retrieve/pii/S2667174321001592

    ArticlePubMedGoogle Scholar

  53. Allen P, Chaddock CA, Egerton A, Howes OD, Bonoldi I, Zelaya F, et al. Resting hyperperfusion of the hippocampus, midbrain, and basal ganglia in people at high risk for psychosis. Am J Psychiatry. 2016 Apr 1;173(4):392–9.

    PubMedGoogle Scholar

  54. Palaniyappan L, Liddle PF. Does the salience network play a cardinal role in psychosis? An emerging hypothesis of insular dysfunction. Vol. 37, Journal of Psychiatry and Neuroscience. Canadian Medical Association; 2012. p. 17–27.

    PubMedGoogle Scholar

  55. Seeley WW, Menon V, Schatzberg AF, Keller J, Glover GH, Kenna H, et al. Dissociable intrinsic connectivity networks for salience processing and executive control. J Neurosci. 2007 Feb 28;27(9):2349–56.

    PubMedGoogle Scholar

  56. Seeley WW. The Salience Network: A Neural System for Perceiving and Responding to Homeostatic Demands. J Neurosci [Internet]. 2019 Dec 11 [cited 2022 Mar 1];39(50):9878–82. Available from: https://www.jneurosci.org/content/39/50/9878

    ArticlePubMedGoogle Scholar

  57. Colizzi M, Weltens N, McGuire P, Van Oudenhove L, Bhattacharyya S. Descriptive Psychopathology of the Acute Effects of Intravenous Delta-9-Tetrahydrocannabinol Administration in Humans. Brain Sci [Internet]. 2019 Apr 1 [cited 2022 May 20];9(4). Available from: https://pubmed.ncbi.nlm.nih.gov/31027219/

    PubMedGoogle Scholar

  58. Colizzi M, Weltens N, Lythgoe DJ, Williams SCR, Van Oudenhove L, Bhattacharyya S. Differential sensitivity to the acute psychotomimetic effects of delta-9-tetrahydrocannabinol associated with its differential acute effects on glial function and cortisol. Psychol Med [Internet]. 2020 [cited 2022 May 20]; Available from: https://pubmed.ncbi.nlm.nih.gov/33107418/

    PubMedGoogle Scholar

  59. Radhakrishnan R, Wilkinson ST, D’Souza DC. Gone to pot-a review of the association between cannabis and psychosis. Front Psychiatry. 2014;5(MAY):54.

    PubMedGoogle Scholar

  60. Grotenhermen F. Pharmacokinetics and Pharmacodynamics of Cannabinoids. Clin Pharmacokinet 2003 424 [Internet]. 2012 Sep 30 [cited 2022 Jun 13];42(4):327–60. Available from: https://link.springer.com/article/10.2165/00003088-200342040-00003

    ArticlePubMedGoogle Scholar

  61. DSM-5 [Internet]. [cited 2022 Mar 23]. Available from: https://www.psychiatry.org/psychiatrists/practice/dsm

    ArticlePubMedGoogle Scholar

  62. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261–76.

    PubMedGoogle Scholar

  63. Spielberger CD. State-Trait Anxiety Inventory. In: The Corsini Encyclopedia of Psychology [Internet]. Hoboken, NJ, USA: John Wiley & Sons, Inc.; 2010 [cited 2020 May 26]. p. 1–1. Available from: http://doi.wiley.com/10.1002/9780470479216.corpsy0943

    ArticlePubMedGoogle Scholar

  64. Mathew RJ, Wilson WH, Humphreys DF, Lowe J V., Wiethe KE. Regional cerebral blood flow after marijuana smoking. J Cereb Blood Flow Metab. 1992;12(5):750–8.

    PubMedGoogle Scholar

  65. Pessiglione M, Seymour B, Flandin G, Dolan RJ, Frith CD. Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans. Nature. 2006 Aug 31;442(7106):1042–5.

    PubMedGoogle Scholar

  66. Murray GK, Knolle F, Ersche KD, Craig KJ, Abbott S, Shabbir SS, et al. Dopaminergic drug treatment remediates exaggerated cingulate prediction error responses in obsessive-compulsive disorder. Psychopharmacology (Berl) [Internet]. 2019 Aug 1 [cited 2022 Mar 23];236(8):2325–36. Available from: https://link.springer.com/article/10.1007/s00213-019-05292-2

    ArticlePubMedGoogle Scholar

  67. Van Hell HH, Jager G, Bossong MG, Brouwer A, Jansma JM, Zuurman L, et al. Involvement of the endocannabinoid system in reward processing in the human brain. Psychopharmacology (Berl). 2012 Feb;219(4):981–90.

    PubMedGoogle Scholar

  68. CRAN - Package lme4 [Internet]. [cited 2022 Apr 29]. Available from: https://cran.r-project.org/web/packages/lme4/index.html

    ArticlePubMedGoogle Scholar

  69. Kuznetsova A, Brockhoff PB, Christensen RHB. lmerTest Package: Tests in Linear Mixed Effects Models [Internet]. Vol. 82, Journal of Statistical Software. 2017 [cited 2021 Mar 1]. Available from: https://github.com/runehaubo/lmerTestR/issues

    ArticlePubMedGoogle Scholar

  70. Team RC. R: A language and environment for statistical computing. R Foundation for Statistical Computing. 2021.

    PubMedGoogle Scholar

  71. Haarsma J, Fletcher PC, Griffin JD, Taverne HJ, Ziauddeen H, Spencer TJ, et al. Precision-weighting of cortical unsigned prediction error signals benefits learning, is mediated by dopamine, and is impaired in psychosis. bioRxiv [Internet]. 2019 Nov 19 [cited 2020 May 5]; Available from: https://www.biorxiv.org/content/10.1101/558478v1

    ArticlePubMedGoogle Scholar

  72. Author B, Davies C, Martin-Santos R, Bhattacharyya S. The Yin and Yang of Cannabis: A Systematic Review of Human Neuroimaging Evidence of the Differential Effects of Δ9-Tetrahydrocannabinol and Cannabidiol. Biol Psychiatry Cogn Neurosci Neuroimaging [Internet]. 2021 Oct [cited 2021 Jan 20];6(6):636–45. Available from: https://pubmed.ncbi.nlm.nih.gov/33414100/

    PubMedGoogle Scholar

  73. Bloomfield MAP, Hindocha C, Green SF, Wall MB, Lees R, Petrilli K, et al. The neuropsychopharmacology of cannabis: A review of human imaging studies. Vol. 195, Pharmacology and Therapeutics. Elsevier Inc.; 2019. p. 132–61.

    PubMedGoogle Scholar

  74. Bernacer J, Corlett PR, Ramachandra P, McFarlane B, Turner DC, Clark L, et al. Methamphetamine-induced disruption of frontostriatal reward learning signals: relation to psychotic symptoms. Am J Psychiatry [Internet]. 2013 Nov 1 [cited 2022 May 3];170(11):1326–34. Available from: https://pubmed.ncbi.nlm.nih.gov/23732871/

    PubMedGoogle Scholar

  75. Kapur S. Psychosis as a state of aberrant salience: A framework linking biology, phenomenology, and pharmacology in schizophrenia. Vol. 160, American Journal of Psychiatry. 2003. p. 13–23.

    PubMedGoogle Scholar

  76. Frith CD. Consciousness, information processing and schizophrenia. Br J Psychiatry [Internet]. 1979 [cited 2022 Apr 26];134(3):225–35. Available from: https://pubmed.ncbi.nlm.nih.gov/509004/

    PubMedGoogle Scholar

  77. Hemsley DR. A simple (or simplistic?) cognitive model for schizophrenia. Behav Res Ther [Internet]. 1993 [cited 2022 Apr 26];31(7):633–45. Available from: https://pubmed.ncbi.nlm.nih.gov/8216165/

    PubMedGoogle Scholar

  78. Feinberg I. Efference copy and corollary discharge: implications for thinking and its disorders. Schizophr Bull [Internet]. 1978 [cited 2022 Apr 26];4(4):636–40. Available from: https://pubmed.ncbi.nlm.nih.gov/734369/

    PubMedGoogle Scholar

  79. Green P, Preston M. Reinforcement of vocal correlates of auditory hallucinations by auditory feedback: a case study. Br J Psychiatry [Internet]. 1981 [cited 2022 Apr 26];139(3):204–8. Available from: https://pubmed.ncbi.nlm.nih.gov/7317701/

    PubMedGoogle Scholar

  80. Gould LN. Auditory hallucinations and subvocal speech. [Internet]. Vol. 144, American Journal of Psychiatry. J Nerv Ment Dis; 1949 [cited 2022 Apr 26]. p. 1364–5. Available from: https://pubmed.ncbi.nlm.nih.gov/18150567/

    PubMedGoogle Scholar

  81. Author B, Davies C, Blest-Hopley G, Veronese M, Ramsey NF, Bossong MG, et al. Task-independent acute effects of delta-9-tetrahydrocannabinol on human brain function and its relationship with cannabinoid receptor gene expression: A neuroimaging meta-regression analysis. bioRxiv [Internet]. 2021 [cited 2022 Apr 25]; Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L2015896172&from=export%0Ahttp://dx.doi.org/10.1101/2021.11.01.466757

    ArticlePubMedGoogle Scholar

  82. Bossong MG, Jansma JM, Bhattacharyya S, Ramsey NF. Role of the endocannabinoid system in brain functions relevant for schizophrenia: An overview of human challenge studies with cannabis or {increment}9-tetrahydrocannabinol (THC). Vol. 52, Progress in Neuro-Psychopharmacology and Biological Psychiatry. Elsevier Inc.; 2014. p. 53–69.

    PubMedGoogle Scholar

  83. FWHM & RESEL details for SPM and FSL, 08/04/13, Neuroimaging Statistics Tips & Tools [Internet]. [cited 2022 Apr 27]. Available from: https://blogs.warwick.ac.uk/nichols/entry/fwhm_resel_details/

    ArticlePubMedGoogle Scholar

  84. Corlett PR, Mollick JA, Kober H. Meta-analysis of human prediction error for incentives, perception, cognition, and action. Neuropsychopharmacol 2022 [Internet]. 2022 Jan 11 [cited 2022 Mar 29];1–11. Available from: https://www.nature.com/articles/s41386-021-01264-3

    ArticlePubMedGoogle Scholar

  85. Bourque J, Potvin S. Cannabis and Cognitive Functioning: From Acute to Residual Effects, From Randomized Controlled Trials to Prospective Designs. Front Psychiatry. 2021 Jun 10;12:919.

    PubMedGoogle Scholar

  86. Dowd EC, Frank MJ, Collins A, Gold JM, Barch DM. Probabilistic Reinforcement Learning in Patients With Schizophrenia: Relationships to Anhedonia and Avolition. Biol psychiatry Cogn Neurosci neuroimaging [Internet]. 2016 Sep 1 [cited 2022 May 19];1(5):460. Available from: /pmc/articles/PMC5098503/

    PubMedPubMed CentralGoogle Scholar

  87. Haarsma J, Fletcher PC, Griffin JD, Taverne HJ, Ziauddeen H, Spencer TJ, et al. Precision weighting of cortical unsigned prediction error signals benefits learning, is mediated by dopamine, and is impaired in psychosis. Mol Psychiatry 2020 269 [Internet]. 2020 Jun 24 [cited 2022 May 19];26(9):5320–33. Available from: https://www.nature.com/articles/s41380-020-0803-8

    ArticlePubMedGoogle Scholar

  88. Hernaus D, Xu Z, Brown EC, Ruiz R, Frank MJ, Gold JM, et al. Motivational deficits in schizophrenia relate to abnormalities in cortical learning rate signals. Cogn Affect Behav Neurosci [Internet]. 2018 Dec 15 [cited 2022 Feb 27];18(6):1338–51. Available from: https://pubmed.ncbi.nlm.nih.gov/30276616/

    PubMedGoogle Scholar

  89. Waltz JA, Xu Z, Brown EC, Ruiz RR, Frank MJ, Gold JM. Motivational Deficits in Schizophrenia Are Associated With Reduced Differentiation Between Gain and Loss-Avoidance Feedback in the Striatum. Biol psychiatry Cogn Neurosci neuroimaging [Internet]. 2018 Mar 1 [cited 2022 May 19];3(3):239–47. Available from: https://pubmed.ncbi.nlm.nih.gov/29486865/

    PubMedGoogle Scholar

  90. Li CT, Lai WS, Liu CM, Hsu YF. Inferring reward prediction errors in patients with schizophrenia: a dynamic reward task for reinforcement learning. Front Psychol [Internet]. 2014 [cited 2022 May 19];5(NOV). Available from: /pmc/articles/PMC4227479/

    PubMedPubMed CentralGoogle Scholar

  91. Kelly P, Jones RT. Metabolism of tetrahydrocannabinol in frequent and infrequent marijuana users. J Anal Toxicol [Internet]. 1992 [cited 2022 Apr 26];16(4):228–35. Available from: https://pubmed.ncbi.nlm.nih.gov/1323733/

    PubMedGoogle Scholar

Comments

Discussion is visible to all readers. Please keep it constructive and relevant.

Sign in to comment or like

  1. No comments yet.